Arq. Bras. Oftalmol. 2024; 87 (3): 10.5935/0004-2749.2023-0038
Total: 2039
Maria Clara O. Magalhães1; Mariana M. G. Sarmento1; Guilherme H. Sant’Anna1; Ana Karine A. Soares2; Camila V. Ventura1,2,3; Camilla S. Rocha2; Bruna V. Ventura1,3
DOI: 10.5935/0004-2749.2023-0038
1. Department of Ophthalmology, Fundação Altino Ventura, Recife, PE, Brazil
2. Department of Research, Fundação Altino Ventura, Recife, PE, Brazil
3. Hospital de Olhos de Pernambuco, Recife, PE, Brazil
Bruna V. Ventura.
E-mail: [email protected]
Disclosure of potential conflicts of interest: Ventura BV: Alcon Laboratories, Inc. (consultant), Johnson & Jonhson Vision, Inc. (consultant) and Cristália Pharmaceutical (consultant). The others authors have any potential conflicts of interest to disclose.
Approved by the following research ethics committee: Fundação Altino Ventura (# 3.912.877).
How to cite this article: